AMLODIPINE-VALSARTAN 5-320 MG
For 30 tablets
Pharmacies pay
$10.53 filed
30 × $0.3511 per EA
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D paid
$20.96 filed
30 × $0.69858 per EA, Part D average
Medicare's price is not your price.
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
The spread
2.0× estimated
Medicare paid 2.0× what pharmacies pay.
Part D averages every strength and form sold under “Amlodipine-Valsartan” / “Amlodipine Besylate/Valsartan” into one figure, so it is not specific to this NDC.
OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)
Cost-plus estimate
$17.11 estimated
$10.53 + $1.58 (15%) + $5.00 fee per fill = $17.11
This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
AMLODIPINE-VALSARTAN 5-320 MG is how the CMS NADAC file names this product. The FDA NDC Directory lists it as amlodipine and valsartan.
FDA gives its dosage form as “tablet, film coated” and “tablet” and its route as oral.
FDA lists 5 labelers (the companies named on the label) for its NDCs, among them Mylan Pharmaceuticals Inc., Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. and Macleods Pharmaceuticals Limited.
FDA lists it under 3 Established Pharmacologic Classes: Angiotensin 2 Receptor Blocker, Calcium Channel Blocker and Dihydropyridine Calcium Channel Blocker.
The NADAC file of 2026-10-14 prices it under 8 NDCs (National Drug Codes).
NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $10.53 for 30 tablets (30 × $0.3511 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.
What NADAC measures · Why 30 tablets · NADAC explanation codes
The 5 labelers
| Labeler | NDCs | Pharmacies pay per unit |
|---|---|---|
| Alembic Pharmaceuticals Inc. | 2 | $0.3511 per EA filed |
| Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2 | $0.3511 per EA filed |
| Macleods Pharmaceuticals Limited | 2 | $0.3511 per EA filed |
| Aurobindo Pharma Limited | 1 | $0.3511 per EA filed |
| Mylan Pharmaceuticals Inc. | 1 | $0.3511 per EA filed |
All 8 NDCs, with labeler and price
- 00378-1723-93 · Mylan Pharmaceuticals Inc. · $0.3511 per EA · eff. 2026-09-23 filed
- 23155-0846-03 · Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. · $0.3511 per EA · eff. 2026-09-23 filed
- 23155-0846-09 · Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. · $0.3511 per EA · eff. 2026-09-23 filed
- 33342-0281-07 · Macleods Pharmaceuticals Limited · $0.3511 per EA · eff. 2026-09-23 filed
- 33342-0281-10 · Macleods Pharmaceuticals Limited · $0.3511 per EA · eff. 2026-09-23 filed
- 62332-0207-30 · Alembic Pharmaceuticals Inc. · $0.3511 per EA · eff. 2026-09-23 filed
- 62332-0207-90 · Alembic Pharmaceuticals Inc. · $0.3511 per EA · eff. 2026-09-23 filed
- 65862-0738-30 · Aurobindo Pharma Limited · $0.3511 per EA · eff. 2026-09-23 filed
Other strengths, forms and brands
3 other products in the NADAC file share the FDA nonproprietary name amlodipine and valsartan with AMLODIPINE-VALSARTAN 5-320 MG.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| AMLODIPINE-VALSARTAN 5-160 MG | $0.26403 per EA filed | $0.69858 per EA filed |
| AMLODIPINE-VALSARTAN 5-320 MG this page | $0.3511 per EA filed | $0.69858 per EA filed |
| AMLODIPINE-VALSARTAN 10-160 MG | $0.32969 per EA filed | $0.69858 per EA filed |
| AMLODIPINE-VALSARTAN 10-320 MG | $0.43177 per EA filed | $0.69858 per EA filed |
Part D is one average per brand and generic name, over every strength and form.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
Compared with its class
The middle of its 8 NDCs’ NADAC prices is $0.3511 per EA filed.
Of the 107 other products in FDA’s Angiotensin 2 Receptor Blocker class priced per EA, 70 have a higher middle NADAC price and 37 a lower one. The one in the middle is OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-10-12.5, at $1.15137 per EA filed (eff. 2026-09-23).
Of the 107 other products in FDA’s Calcium Channel Blocker class priced per EA, 66 have a higher middle NADAC price and 41 a lower one. The one in the middle is DILTIAZEM 24H ER(LA) 240 MG TB, at $1.0087 per EA filed (eff. 2026-09-23).
Of the 67 other products in FDA’s Dihydropyridine Calcium Channel Blocker class priced per EA, 45 have a higher middle NADAC price and 22 a lower one. The one in the middle is ISRADIPINE 2.5 MG CAPSULE, at $1.13676 per EA filed (eff. 2026-09-23).
Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What Medicare paid
Medicare Part D paid $20.96 for 30 tablets, at an average of $0.69858 per EA in 2024 (2024-01-01 to 2024-12-31) for “Amlodipine-Valsartan” and “Amlodipine Besylate/Valsartan”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).
That average covers 437,348 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.
Medicare's price is not your price.
What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 30 tablets? Is it lower than what I would pay through my insurance?
- If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Questions
- Why is the comparison with Medicare for AMLODIPINE-VALSARTAN 5-320 MG labelled estimated?
- Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Amlodipine-Valsartan / Amlodipine Besylate/Valsartan: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name.
Related pages
Its pharmacologic classes
Related in the same class
- AMLODIPINE-OLMESARTAN 10-20 MG
- TELMISARTAN-AMLODIPINE 40-10
- EXFORGE 10-320 MG TABLET
- TRIBENZOR 40-10-25 MG TABLET
- EXFORGE HCT 10-320-25 MG TAB